SPG21 Antikörper (AA 211-306)
-
- Target Alle SPG21 Antikörper anzeigen
- SPG21 (Spastic Paraplegia 21 (SPG21))
-
Bindungsspezifität
- AA 211-306
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser SPG21 Antikörper ist unkonjugiert
-
Applikation
- ELISA
- Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant SPG21.
- Sequenz
- PHKIRDIPVT IMDVFDQSAL STEAKEEMYK LYPNARRAHL KTGGNFPYLC RSAEVNLYVQ IHLLQFHGTK YAAIDPSMVS AEELEVQKGS LGISQE
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- SPG21 (NP_057714, 211 a.a. ~ 306 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 2B11
- Isotyp
- IgG2a
- Top Product
- Discover our top product SPG21 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
- Target
- SPG21 (Spastic Paraplegia 21 (SPG21))
- Andere Bezeichnung
- SPG21 (SPG21 Produkte)
- Hintergrund
-
Full Gene Name: spastic paraplegia 21 (autosomal recessive, Mast syndrome)
Synonyms: ACP33,BM-019,GL010,MASPARDIN,MAST - Gen-ID
- 51324
- NCBI Accession
- NM_016630
-